Behavioral Therapy to Augment Oral Naltrexone for Opioid Dependence: A Ceiling on Effectiveness?
Saved in:
| Title: | Behavioral Therapy to Augment Oral Naltrexone for Opioid Dependence: A Ceiling on Effectiveness? |
|---|---|
| Authors: | Nunes, Edward V. (AUTHOR), Rothenberg, Jami L. (AUTHOR), Sullivan, Maria A. (AUTHOR), Carpenter, Kenneth M. (AUTHOR), Kleber, Herbert D. (AUTHOR) |
| Source: | American Journal of Drug & Alcohol Abuse. Nov2006, Vol. 32 Issue 4, p503-517. 15p. 2 Charts, 1 Graph. |
| Subjects: | Behavior therapy, Psychiatric drugs, Clinical trials, Drug abuse, Naltrexone, Narcotic antagonists, Drug addiction, People with drug addiction, Substance abuse treatment |
| Abstract: | The effectiveness of antagonist maintenance with oral naltrexone for opioid dependence has been limited by high dropout rates. Behavioral Naltrexone Therapy (BNT) was developed to improve retention on oral naltrexone by integrating voucher incentives, Motivational and Cognitive Behavioral therapies, and a significant other for monitoring medication adherence. In a 6-month, randomized, controlled trial in heroin dependent patients, BNT (N = 36) improved retention in treatment compared to a standard treatment control (Compliance Enhancement (CE); N = 33) (log rank = 4.28; p = .04). Most patients retained beyond 3 months achieved abstinence from opioids, but retention at 6 months was only 22% on BNT and 9% on CE. A systematic review of related controlled trials revealed similar effect sizes in the small to medium range, and substantial dropout. There may be a limit on the extent to which behavioral therapy can overcome poor adherence to oral naltrexone. Future research should consider combinations of behavioral methods with new long-acting injectable or implantable naltrexone formulations. [ABSTRACT FROM AUTHOR] |
| Copyright of American Journal of Drug & Alcohol Abuse is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 23219834 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Behavioral Therapy to Augment Oral Naltrexone for Opioid Dependence: A Ceiling on Effectiveness? – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Nunes%2C+Edward+V%2E%22">Nunes, Edward V.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rothenberg%2C+Jami+L%2E%22">Rothenberg, Jami L.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sullivan%2C+Maria+A%2E%22">Sullivan, Maria A.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Carpenter%2C+Kenneth+M%2E%22">Carpenter, Kenneth M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kleber%2C+Herbert+D%2E%22">Kleber, Herbert D.</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22American+Journal+of+Drug+%26+Alcohol+Abuse%22">American Journal of Drug & Alcohol Abuse</searchLink>. Nov2006, Vol. 32 Issue 4, p503-517. 15p. 2 Charts, 1 Graph. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Behavior+therapy%22">Behavior therapy</searchLink><br /><searchLink fieldCode="DE" term="%22Psychiatric+drugs%22">Psychiatric drugs</searchLink><br /><searchLink fieldCode="DE" term="%22Clinical+trials%22">Clinical trials</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+abuse%22">Drug abuse</searchLink><br /><searchLink fieldCode="DE" term="%22Naltrexone%22">Naltrexone</searchLink><br /><searchLink fieldCode="DE" term="%22Narcotic+antagonists%22">Narcotic antagonists</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+addiction%22">Drug addiction</searchLink><br /><searchLink fieldCode="DE" term="%22People+with+drug+addiction%22">People with drug addiction</searchLink><br /><searchLink fieldCode="DE" term="%22Substance+abuse+treatment%22">Substance abuse treatment</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: The effectiveness of antagonist maintenance with oral naltrexone for opioid dependence has been limited by high dropout rates. Behavioral Naltrexone Therapy (BNT) was developed to improve retention on oral naltrexone by integrating voucher incentives, Motivational and Cognitive Behavioral therapies, and a significant other for monitoring medication adherence. In a 6-month, randomized, controlled trial in heroin dependent patients, BNT (N = 36) improved retention in treatment compared to a standard treatment control (Compliance Enhancement (CE); N = 33) (log rank = 4.28; p = .04). Most patients retained beyond 3 months achieved abstinence from opioids, but retention at 6 months was only 22% on BNT and 9% on CE. A systematic review of related controlled trials revealed similar effect sizes in the small to medium range, and substantial dropout. There may be a limit on the extent to which behavioral therapy can overcome poor adherence to oral naltrexone. Future research should consider combinations of behavioral methods with new long-acting injectable or implantable naltrexone formulations. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of American Journal of Drug & Alcohol Abuse is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=23219834 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/00952990600918973 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 15 StartPage: 503 Subjects: – SubjectFull: Behavior therapy Type: general – SubjectFull: Psychiatric drugs Type: general – SubjectFull: Clinical trials Type: general – SubjectFull: Drug abuse Type: general – SubjectFull: Naltrexone Type: general – SubjectFull: Narcotic antagonists Type: general – SubjectFull: Drug addiction Type: general – SubjectFull: People with drug addiction Type: general – SubjectFull: Substance abuse treatment Type: general Titles: – TitleFull: Behavioral Therapy to Augment Oral Naltrexone for Opioid Dependence: A Ceiling on Effectiveness? Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nunes, Edward V. – PersonEntity: Name: NameFull: Rothenberg, Jami L. – PersonEntity: Name: NameFull: Sullivan, Maria A. – PersonEntity: Name: NameFull: Carpenter, Kenneth M. – PersonEntity: Name: NameFull: Kleber, Herbert D. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: Nov2006 Type: published Y: 2006 Identifiers: – Type: issn-print Value: 00952990 Numbering: – Type: volume Value: 32 – Type: issue Value: 4 Titles: – TitleFull: American Journal of Drug & Alcohol Abuse Type: main |
| ResultId | 1 |